Back to Newsroom
Back to Newsroom

Helping End HIV - Gilead Sciences

Thursday, 12 September 2024 09:35 AM

Gilead Sciences

NORTHAMPTON, MA / ACCESSWIRE / September 12, 2024 / Each scientific discovery gets us one step closer to our shared goal of ending the HIV epidemic. As a leader in HIV treatment and prevention, we'll continue to build on our legacy and create innovative solutions to address the diverse needs of all people affected by HIV.

Watch the video to learn more about our work.

Gilead Sciences
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.

View additional multimedia and more ESG storytelling from Gilead Sciences on 3blmedia.com.

Contact Info:
Spokesperson: Gilead Sciences
Website: https://www.3blmedia.com/profiles/gilead-sciences
Email: [email protected]

SOURCE: Gilead Sciences

Topic:
Environmental, Social and Governance
Back to newsroom
Back to Newsroom

Contact Us Today


If you have questions or want to learn more about our products, our team’s here to help!

Share by: